Mingchao Xie

1.0k total citations
14 papers, 165 citations indexed

About

Mingchao Xie is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Mingchao Xie has authored 14 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Mingchao Xie's work include Lung Cancer Research Studies (8 papers), Cancer therapeutics and mechanisms (4 papers) and Cell death mechanisms and regulation (3 papers). Mingchao Xie is often cited by papers focused on Lung Cancer Research Studies (8 papers), Cancer therapeutics and mechanisms (4 papers) and Cell death mechanisms and regulation (3 papers). Mingchao Xie collaborates with scholars based in United States, Spain and Japan. Mingchao Xie's co-authors include Zhongwu Lai, Jonathan R. Dry, Elizabeth A. Harrington, J. Carl Barrett, Yashaswi Shrestha, Darren Hodgson, Ethan S. Sokol, Luis Paz‐Ares, Malay Haldar and R. Lor Randall and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Mingchao Xie

14 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingchao Xie United States 9 103 65 53 50 28 14 165
Loreall Pooler United States 8 41 0.4× 87 1.3× 36 0.7× 8 0.2× 39 1.4× 13 207
Victoria Damerell South Africa 7 52 0.5× 87 1.3× 45 0.8× 7 0.1× 30 1.1× 8 161
Eli Grunblatt United States 5 149 1.4× 161 2.5× 42 0.8× 82 1.6× 46 1.6× 11 268
Marta Ferreira Portugal 6 39 0.4× 87 1.3× 46 0.9× 9 0.2× 47 1.7× 16 177
Daliah Tsoref Israel 6 59 0.6× 66 1.0× 23 0.4× 12 0.2× 33 1.2× 15 166
Kerstie Johnson United Kingdom 6 64 0.6× 114 1.8× 27 0.5× 10 0.2× 42 1.5× 12 163
Lotus Yung United States 7 89 0.9× 45 0.7× 38 0.7× 14 0.3× 21 0.8× 12 133
Lok-Hei Chan United States 8 46 0.4× 144 2.2× 23 0.4× 14 0.3× 49 1.8× 13 223
Takaaki Yoshikawa Japan 6 82 0.8× 112 1.7× 17 0.3× 12 0.2× 36 1.3× 17 196
Xiaobing Le China 5 67 0.7× 82 1.3× 46 0.9× 8 0.2× 69 2.5× 11 163

Countries citing papers authored by Mingchao Xie

Since Specialization
Citations

This map shows the geographic impact of Mingchao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingchao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingchao Xie more than expected).

Fields of papers citing papers by Mingchao Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingchao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingchao Xie. The network helps show where Mingchao Xie may publish in the future.

Co-authorship network of co-authors of Mingchao Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Mingchao Xie. A scholar is included among the top collaborators of Mingchao Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingchao Xie. Mingchao Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Reinmuth, Niels, Óscar Juan, Dariusz M. Kowalski, et al.. (2024). Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study. Clinical Cancer Research. 30(18). 4055–4067. 5 indexed citations
3.
Lai, Zhongwu, Ethan S. Sokol, Mingchao Xie, et al.. (2022). Landscape of homologous recombination deficiencies in solid tumours: analyses of two independent genomic datasets. BMC Cancer. 22(1). 13–13. 28 indexed citations
4.
Xie, Mingchao, Helen Broadhurst, Zhongwu Lai, et al.. (2022). Abstract CT024: Durvalumab (D) + platinum-etoposide (EP) in 1L extensive-stage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN. Cancer Research. 82(12_Supplement). CT024–CT024. 17 indexed citations
5.
Xie, Mingchao, Andreas Spitzmüller, Harald Hessel, et al.. (2022). 155 MHC class I antigen presentation is associated with an inflamed SCLC tumor microenvironment characterized by a higher density of cytotoxic T-cells in closer proximity to tumor cells. Regular and Young Investigator Award Abstracts. A168–A168. 1 indexed citations
6.
Reinmuth, Niels, M.C. Garassino, Yuanbin Chen, et al.. (2022). 141O Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study. Annals of Oncology. 33. S97–S98. 3 indexed citations
7.
Garassino, Marina Chiara, Yashaswi Shrestha, Mingchao Xie, et al.. (2021). MA16.06 Durvalumab ± Tremelimumab + Platinum-Etoposide in 1L ES-SCLC: Exploratory Analysis of HLA Genotype and Survival in CASPIAN. Journal of Thoracic Oncology. 16(10). S939–S939. 10 indexed citations
8.
Goldman, Jonathan W., Marina Chiara Garassino, Yuanbin Chen, et al.. (2020). LBA86 Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L ES-SCLC: Characterization of long-term clinical benefit and tumour mutational burden (TMB) in CASPIAN. Annals of Oncology. 31. S1212–S1213. 17 indexed citations
9.
Goldman, Jonathan W., Marina Chiara Garassino, Yuanbin Chen, et al.. (2020). 379MO Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L ES-SCLC: Characterization of long-term clinical benefit and tumour mutational burden (TMB) in CASPIAN. Annals of Oncology. 31. S1388–S1389. 2 indexed citations
10.
Merino, Diana M., Matt Butler, Vincent Funari, et al.. (2019). TMB standardization by alignment to reference standards: Phase II of the Friends of Cancer Research TMB Harmonization Project.. Journal of Clinical Oncology. 37(15_suppl). 2624–2624. 12 indexed citations
11.
Jones, Kevin B., Jared J. Barrott, Mingchao Xie, et al.. (2016). The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis. Oncogene. 35(38). 5021–5032. 39 indexed citations
12.
Jiang, Junjun, et al.. (2015). SPATA4 Counteracts Etoposide-Induced Apoptosis <i>via</i> Modulating Bcl-2 Family Proteins in HeLa Cells. Biological and Pharmaceutical Bulletin. 38(10). 1458–1463. 9 indexed citations
13.
Xie, Mingchao, et al.. (2007). Cloning and characterization of chicken SPATA4 gene and analysis of its specific expression. Molecular and Cellular Biochemistry. 306(1-2). 79–85. 13 indexed citations
14.
Chang, Junlei, et al.. (2005). Endoplasmic Reticulum Mediated Necrosis-like Apoptosis of HeLa Cells Induced by Ca2+ Oscillation. BMB Reports. 38(6). 709–716. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Loreall Pooler Breakdown of academic impact, for papers by Victoria Damerell Breakdown of academic impact, for papers by Eli Grunblatt Breakdown of academic impact, for papers by Marta Ferreira Breakdown of academic impact, for papers by Daliah Tsoref Breakdown of academic impact, for papers by Kerstie Johnson Breakdown of academic impact, for papers by Lotus Yung Breakdown of academic impact, for papers by Lok-Hei Chan Breakdown of academic impact, for papers by Takaaki Yoshikawa Breakdown of academic impact, for papers by Xiaobing Le
Rankless by CCL
2026